Logo

SISCAPA

Sciex Moves to Develop Protein Quant Content With Fred Hutch-CPTAC Immuno-MRM Deal
Premium

The company plans to offer the immuno-MRM assays as kits covering sample prep and protein digestion as well as immuno-enrichment of specific peptides.

NCI Building Collection of Targeted Mass Spec Assays to Study RAS Signaling
Premium

The project aims to develop multiple-reaction monitoring mass spec and immuno-MRM mass spec assays for roughly 100 proteins involved in RAS signaling.

New England Peptide, SISCAPA Collaborate on Peptide Standards

NEW YORK (GenomeWeb) – New England Peptide and SISCAPA Assay Technologies are collaborating to manufacture and sell stable isotope standard peptides for use in SISCAPA's protein quantification assays.

OriGene Developing Antibodies for SISCAPA Assays with NCI Contract

NEW YORK (GenomeWeb News) – OriGene Technologies announced that it has received a contract from the National Cancer Institute to develop high affinity anti-peptide antibodies for SISCAPA assays.

Bruker, SAT Ink Deal to Continue Collaboration on SISCAPA-MALDI Protein Assays

NEW YORK (GenomeWeb News) – Bruker said today at the 12th annual meeting of the Human Proteome Organization in Yokohama, Japan, that it has launched a second-phase collaboration agreement with SISCAPA Assays Technologies to apply the SISCAPA immunoenrichment mass spec method to its MALDI-TOF inst
Nov 16, 2012

Researchers Develop Seven-Second MRM-MS Workflow Using Agilent's RapidFire Technology
Premium

Oct 26, 2012

Immundiagnostik Deal Offers Thermo Fisher Chance to Highlight Immunoaffinity Mass Spec Workflows
Premium

Sep 21, 2012

Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption
Premium

Sep 21, 2012

NCI Commits $10M in SBIR Funding for Projects Including Proteomics Reagent Development
Premium

Sep 7, 2012

PNNL Team Develops Antibody-Free SRM-MS Method for Low-Abundance Biomarker Quantification
Premium

Jan 30, 2012

Bruker, SISCAPA Assay Tech Study Suggests MALDI-MS Suitable for Clinical Protein Quantitation
Premium

Jan 20, 2012

New Instruments, Applications Powering Rise of MALDI-MS as Clinical Proteomics Platform
Premium

Jan 13, 2012

Agilent Partners with Integrated Diagnostics, Further Signaling Focus on MRM-MS as Clinical Platform
Premium

Jan 6, 2012

Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
Premium

Oct 28, 2011

Quintiles to Buy Advion's Bioservices Division, Including SISCAPA Services
Premium

Oct 14, 2011

Agilent Awards Broad's Carr $1.2M in Funding and Equipment to Support Peptide Quantitation Work
Premium

Sep 23, 2011

With IBI Buy, Thermo Aims to Expand In-House Diagnostics Offerings, Position Mass Spec for the Clinic
Premium

Jul 29, 2011

New Products: Jul 29, 2011
Premium

Jul 27, 2011

Advion, SISCAPA Partner to Offer Assay Services

Jul 22, 2011

Lung Cancer Study Highlights Current Limitations of MALDI Mass Spec
Premium

Jun 23, 2011

Tecan, TGen, and Biodesign Institute Develop Proteomic Sample Prep Platform

Jun 17, 2011

Leigh Anderson Launches New Firm to Commercialize SISCAPA Technology
Premium

Jun 3, 2011

Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
Premium

Mar 4, 2011

Biocius Buy Key to Agilent's Clinical Proteomics Plans
Premium

Feb 11, 2011

Automation, Increased Throughput Key to Moving Mass Spec-Based Proteomics into the Clinic
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.